Skip to main content
Top
Published in: Head & Neck Oncology 1/2011

Open Access 01-12-2011 | Case report

Non-Hodgkin lymphoma affecting the tongue: unusual intra-oral location

Authors: Francesco Inchingolo, Marco Tatullo, Fabio M Abenavoli, Massimo Marrelli, Alessio D Inchingolo, Angelo M Inchingolo, Gianna Dipalma

Published in: Head & Neck Oncology | Issue 1/2011

Login to get access

Abstract

Introduction

The expression non Hodgkin lymphoma is used to cover a wide group of lymphoid neoplasias unrelated to Hodgkin's disease, due to the huge histological variety and the tendency to affect organs and tissues that does not physiologically contain lymphoid cells.
The intraoral location is not frequent (3 - 5 percent of cases) and the initial manifestations of the disease rarely take place here.

Case presentation

We describe the case of a 73 years old Italian caucasian male who came to our attention with a tongue lesion. The clinical manifestation was macroglossia and bleeding, probably deriving from the tongue-bite injuries.
The patient had been complaining of dyspnea for 48 hours.

Conclusion

A tongue affected by non-Hodgkin's lymphoma rarely occurs. In spite of this, this possibility should always be considered for the differential diagnosis of benign and malignant lesions affecting such area.
A rapid diagnostic assessment, together with an adequate histopathologic verification, are indeed essential to improve the management and the prognosis of this disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ping Lu: Staging and Classification of Lymphoma. Semin Nucl Med. 2005, Elsevier Inc, 35: 160-164. 10.1053/j.semnuclmed.2005.02.002. Ping Lu: Staging and Classification of Lymphoma. Semin Nucl Med. 2005, Elsevier Inc, 35: 160-164. 10.1053/j.semnuclmed.2005.02.002.
2.
go back to reference Jaffe ES, Harris NL, Stein H: World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. 2001, Lyon, IARC Press Jaffe ES, Harris NL, Stein H: World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues. 2001, Lyon, IARC Press
3.
go back to reference Ficarra G: Manuale di Patologia e Medicina orale, terza edizione. 2006, Casa editrice Mcgraw-Hill Ficarra G: Manuale di Patologia e Medicina orale, terza edizione. 2006, Casa editrice Mcgraw-Hill
4.
go back to reference Whitt JC, Dunlap CL, Martin KF: Oral Hodgkin lymphoma: a wolf in wolf's clothing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 104: e45-e51. 10.1016/j.tripleo.2007.06.002.CrossRefPubMed Whitt JC, Dunlap CL, Martin KF: Oral Hodgkin lymphoma: a wolf in wolf's clothing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 104: e45-e51. 10.1016/j.tripleo.2007.06.002.CrossRefPubMed
5.
go back to reference Regezi JA, Sciubba JJ: Patologia orale, dalla diagnosi alla terapia. Terza edizione. Delfino editore. 2001 Regezi JA, Sciubba JJ: Patologia orale, dalla diagnosi alla terapia. Terza edizione. Delfino editore. 2001
6.
go back to reference Zhong Yazhen: Non-Hodgkin Lymphoma. What Primary Care Professionals Need to Know. The Journal for Nurse Practitioners - JNP. 2006 Zhong Yazhen: Non-Hodgkin Lymphoma. What Primary Care Professionals Need to Know. The Journal for Nurse Practitioners - JNP. 2006
7.
go back to reference Franceschi S, Maso LD, La Vecchia C: Human cancer: advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer. 1999, 83 (4): 481-485. 10.1002/(SICI)1097-0215(19991112)83:4<481::AID-IJC8>3.0.CO;2-5.CrossRefPubMed Franceschi S, Maso LD, La Vecchia C: Human cancer: advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer. 1999, 83 (4): 481-485. 10.1002/(SICI)1097-0215(19991112)83:4<481::AID-IJC8>3.0.CO;2-5.CrossRefPubMed
8.
go back to reference Fisher SG, Fisher RI: The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004, 23 (38): 6524-6534. 10.1038/sj.onc.1207843.CrossRefPubMed Fisher SG, Fisher RI: The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004, 23 (38): 6524-6534. 10.1038/sj.onc.1207843.CrossRefPubMed
9.
go back to reference Muller AM, Ihorst G, Mertelsmann R, Engelhardt M: Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005, 84 (1): 1-12. 10.1007/s00277-004-0939-7.CrossRefPubMed Muller AM, Ihorst G, Mertelsmann R, Engelhardt M: Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005, 84 (1): 1-12. 10.1007/s00277-004-0939-7.CrossRefPubMed
10.
go back to reference Rugarli C: Medicina Interna Sistematica, quarta edizione. Masson. 2005 Rugarli C: Medicina Interna Sistematica, quarta edizione. Masson. 2005
11.
go back to reference National Cancer Institute: Adult non-Hodgkin's lymphoma treatment. 2005 National Cancer Institute: Adult non-Hodgkin's lymphoma treatment. 2005
12.
go back to reference Clearly KR, Batsakis JG: Sinonasal lymphomas. Ann Otol Rhinol Laryngol. 1994, 03: 911-4.CrossRef Clearly KR, Batsakis JG: Sinonasal lymphomas. Ann Otol Rhinol Laryngol. 1994, 03: 911-4.CrossRef
13.
go back to reference Vaswani B, Shah M, Shah PM, Parikh BJ, Anand AS, Sharma G: Non Hodgkin's Lymphoma of Tongue. A Case Report. Indian Journal of Medical & Paediatric Oncology. 2008, 29 (1): Vaswani B, Shah M, Shah PM, Parikh BJ, Anand AS, Sharma G: Non Hodgkin's Lymphoma of Tongue. A Case Report. Indian Journal of Medical & Paediatric Oncology. 2008, 29 (1):
Metadata
Title
Non-Hodgkin lymphoma affecting the tongue: unusual intra-oral location
Authors
Francesco Inchingolo
Marco Tatullo
Fabio M Abenavoli
Massimo Marrelli
Alessio D Inchingolo
Angelo M Inchingolo
Gianna Dipalma
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2011
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-3-1

Other articles of this Issue 1/2011

Head & Neck Oncology 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine